RECRUITING
I'm interested ...!!
Molecular Biology of Polycythemia and Thrombocytosis
Our study is designed to characterize the clinical picture and genetic pattern of Polycythemia and Thrombocytosis. The purpose of this project is to find a gene and its mutation that causes these disorders. When this is accomplished, new therapies to control and eventually cure the disorder can be designed.
Conditions:
🦠 Polycythemia 🦠 Thrombocytosis
🗓️ Study Start (Actual) July 2006
🗓️ Primary Completion (Estimated) July 2028
✅ Study Completion (Estimated) July 2028
👥 Enrollment (Estimated) 200
🔬 Study Type OBSERVATIONAL
📊 Phase N/A
Locations:
📍 Salt Lake City, Utah, United States

📋 Eligibility Criteria

Description

    Inclusion Criteria:

    • 1. Subjects with an elevated hemoglobin concentration (\>18 in males and \>16 in females)
    • 2. Subjects with an elevated platelet count (\>450,000)

    Exclusion Criteria:

    • 1. Subjects who have a known acquired cause of polycythemia and thrombocytosis
    • 2. Subjects with heart disease, left to right heart shunt or severe pulmonary disease
Ages Eligible for Study: N/A to N/A (CHILD, ADULT, OLDER_ADULT)
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: No

🗓️ Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

  • First Submitted 23 July 2008
  • First Submitted that Met QC Criteria 24 July 2008
  • First Posted 25 July 2008

Study Record Updates

  • Last Update Submitted that Met QC Criteria 19 December 2023
  • Last Update Posted 20 December 2023
  • Last Verified December 2023
I'm interested ...!!